featured
Immediate, Single Instillation of Intravesical Mitomycin C Beneficial in Non–Muscle Invasive Bladder Cancer Regardless of Prognostic Risk
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Urologic Oncology: Seminars and Original Investigations
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
An Immediate, Single Intravesical Instillation of Mitomycin C Is of Benefit in Patients With Non-Muscle-Invasive Bladder Cancer Irrespective of Prognostic Risk Groups
Urol. Oncol 2018 Jul 28;[EPub Ahead of Print], J Bosschieter, JA Nieuwenhuijzen, AN Vis, T van Ginkel, BI Lissenberg-Witte, GMA Beckers, RJA van MoorselaarFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.